Ian Jacobson

Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom.

Phairson Medical Ltd. researches and develops novel biopharmaceutical products and devices. The private company is based in London, UK.

Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom.

Part of Ernst & Young Global Ltd., Arthur Andersen (UK) is a British company that provides accounting services. The company is based in Reading, UK.

Contura International A/S develops and markets soft tissue fillers to the healthcare industry. Its products include Bulkamid, a class leading urethral bulking agent for treatment of stress urinary incontinence; and Aquamid, an aesthetic injectable volumiser. The company was founded on March 1, 2000 and is headquartered in Søborg, Denmark.

Pharmacia Ltd. provides business support services. The company is headquartered in Sandwich, the United Kingdom.

Conavi Medical, Inc. develops, manufactures, sells, and supports technologies to help guide minimally invasive procedures. It provides imaging devices for use during procedures performed by electrophysiologists and interventional cardiologists. The company was founded by Brian Courtney and Amandeep Thind in 2007 and is headquartered in Toronto, Canada.

Part of H.I.G. Capital LLC, Aspire Pharma Ltd. is a British company that licenses and develops products with innovative formulations, value for money for payors, and reliable supply agreements. The private company is based in Petersfield, UK. Aspire Pharma is present in the generics, speciality generics, branded medicines, and medical device sectors. The company was founded in 2009 by Graham Julian Fraser-Pye. The CEO is Richard Michael Condon. Aspire Pharma was acquired by H.I.G. Capital LLC on September 24, 2021.

Juno Pharmaceuticals Corp. specializes in bringing complex and high-value generic and biosimilar products to the Canadian market. The company is based in Mississauga, Canada, and has subsidiaries in Canada. The Juno management team possesses decades of pharmaceutical industry experience and has a track record of driving strategic growth through the identification of niche products and disciplined construction of robust product pipelines. Juno licenses and acquires specialized pharmaceutical products that have limited competitors and inherent barriers to market entry. The Canadian company was founded in 2019, and Mark Mantel has been the CEO of the company since 2022.